Premature Ejaculation (PE)
Symptoms, Causes & Treatment
Understanding premature ejaculation: what causes it, what treatments are available, and how to regain confidence and control in sexual relationships.
What Is Premature Ejaculation?
Premature ejaculation (PE) is the most common male sexual dysfunction, affecting an estimated 20–30% of men across all age groups. It is defined as ejaculation that consistently occurs sooner than the man or his partner would wish – typically within one to two minutes of penetration – and is accompanied by significant personal distress or interpersonal difficulty.
Despite being so prevalent, PE is one of the most underreported and undertreated sexual health conditions. Many men are embarrassed to raise it with a clinician, assume nothing can be done, or have accepted it as a permanent feature of their sexuality. In reality, PE is highly treatable, and the majority of men who seek help experience significant and lasting improvement.
PE is classified into two main types:
Lifelong (primary) PE – present from the first sexual experience, occurring consistently in most or all situations. Thought to have a stronger neurobiological basis, with evidence for a genetic component involving serotonin receptor sensitivity.
Acquired (secondary) PE – develops after a period of normal ejaculatory function. More commonly associated with psychological factors, relationship changes, erectile dysfunction, prostatitis, or hyperthyroidism.
A third category – natural variable PE – refers to inconsistent or situationally specific rapid ejaculation that is considered within the normal range of male sexual function and does not warrant clinical diagnosis.
What Are the Symptoms of PE?
PE is defined by its impact on the individual and relationship, not by a specific ejaculation time. The distress and loss of control are the defining features.
Ejaculation consistently occurring before or within approximately 1 minute of penetration · Little or no control over timing of ejaculation · Significant distress, frustration, or avoidance of sexual intimacy · May be lifelong (primary) or acquired (secondary after period of normal function)
PE with associated erectile dysfunction (both require assessment) · Acquired PE with pain on ejaculation (possible prostatitis) · PE causing significant relationship difficulties or psychological distress · PE associated with new or worsening penile hypersensitivity
See a clinician if PE is accompanied by ejaculatory pain (possible prostatitis), blood in semen (haematospermia), or if you are also experiencing erectile dysfunction — both conditions may need treatment simultaneously.
What Causes Premature Ejaculation?
PE results from an interaction between biological predisposition (serotonin pathways, penile sensitivity) and psychological factors (anxiety, learning). Both lifelong and acquired PE respond to treatment.
PE is classified as lifelong (present from first sexual experience) or acquired (developing after a period of normal ejaculation). Different causes and treatments apply to each type.
PE is driven by a combination of hypersensitivity of the glans penis, overactive ejaculatory reflex, low serotonin levels in the ejaculatory pathway, and anxiety amplifying the reflex threshold.
Performance anxiety, relationship stress, fear of pregnancy, sexual repression, and early sexual experiences all contribute significantly to lifelong PE. Psychological therapy is highly effective.
STIs are transmitted through unprotected vaginal, anal, or oral sex. Some (herpes, HPV, syphilis) can spread through skin-to-skin contact even without penetration or visible symptoms.
Many STIs, particularly chlamydia, gonorrhoea, and early HIV, cause no symptoms at all. Regular testing is the only way to detect them — waiting for symptoms means delayed treatment and onward transmission.
Condoms reduce STI transmission by 85–98% when used consistently and correctly. They are less effective for infections spread by skin contact (herpes, HPV, syphilis) where lesions extend beyond the condom-covered area.
Key Risk Factors
How Is PE Diagnosed?
PE is diagnosed clinically through history. The PEDT questionnaire and IELT (intravaginal ejaculatory latency time) estimate help classify severity and guide treatment choice. Investigation for underlying conditions (prostatitis, thyroid disease) is performed when clinically indicated.
How Is PE Treated?
PE responds well to treatment. Options include pharmacological, behavioural, psychological, and combination approaches.
Supportive Measures
Open communication with your partner about PE significantly reduces anxiety and improves outcomes. Mindfulness practice during sex — focusing on sensation rather than performance — helps interrupt the anxiety-arousal cycle. Thick-ribbed condoms reduce glans sensitivity. Distraction techniques (the non-demand focus approach) are part of sex therapy programmes for PE.
Long-Term Management of PE
PE may recur after stopping medication or if psychological triggers reappear. Combining pharmacological treatment with behavioural therapy and sex therapy produces the most durable outcomes. Some men use topical anaesthetic long-term; others prefer dapoxetine on-demand. There is no single right answer — treatment should match the individual’s preferences, relationship context, and goals.
When Should You Seek Help for PE?
PE with ejaculatory pain and fever (possible prostatitis requiring urgent treatment) · PE with new acute difficulty achieving erection in a younger man (cardiovascular risk assessment warranted).
PE is affecting your relationship or quality of life · You also have erectile dysfunction · PE developed suddenly after a period of normal function · You have ejaculatory pain suggesting prostatitis · You want to discuss dapoxetine or topical anaesthetic.
How to Manage & Improve PE
PE management is about developing control, reducing anxiety, and addressing the physical and psychological components that contribute to the condition.
Behavioural techniques — the stop-start method and squeeze technique — are highly effective for PE and can be practised alone or with a partner. Combine with mindfulness to reduce performance anxiety.
Couples therapy and sex therapy address relationship and communication issues that often drive or perpetuate PE. Involving a partner in treatment significantly improves outcomes and reduces distress.
Masturbating 1–2 hours before partnered sex reduces penile sensitivity and can increase latency. Regular sexual activity and open communication with partners reduces the anxiety cycle that worsens PE.
Annual STI testing is recommended for all sexually active people. Those with multiple partners should test every 3 months. Free NHS testing is available at sexual health clinics, online via SHGM/SH:24, and from GP surgeries.
Notify all recent sexual partners when diagnosed with an STI so they can be tested and treated. Partner notification can be done directly or anonymously through the sexual health clinic (contact tracing service).
If you are HIV-positive and on effective ART with an undetectable viral load, you cannot transmit HIV to sexual partners (U=U — Undetectable = Untransmittable). This is one of the most important advances in HIV medicine.
Speak to a Clinician About Premature Ejaculation
Through The GP Service, a licensed clinician can assess PE, exclude underlying causes, and prescribe dapoxetine or SSRIs — all online without embarrassment.
Expert clinical advice, when you need it.
Premature Ejaculation FAQs
PE affects approximately 20–30% of men at some point — making it the most common male sexual dysfunction. Many men suffer in silence due to embarrassment, assuming it is shameful or untreatable. In reality, PE is a well-recognised medical condition with highly effective treatments. Dapoxetine (a short-acting SSRI licensed specifically for PE) can more than triple ejaculatory latency time in clinical trials. Behavioural techniques (stop-start, squeeze) are effective for lifelong PE. Combining medication with psychological or couples therapy produces the best outcomes. Most men with PE who seek treatment experience significant improvement.
STI testing is recommended annually for all sexually active people. Those with new or multiple partners should test every 3 months. Testing is free at NHS sexual health clinics and from online services (SH:24, SHGM). You do not need symptoms to be tested — most STIs cause no symptoms. A full STI screen covers chlamydia, gonorrhoea, syphilis, HIV, hepatitis B, and hepatitis C. Specific sites tested (urine, swabs, blood) depend on your sexual practices. Results are usually available within 1–2 weeks. Positive results trigger automatic partner notification advice.
Not all STIs are curable, but all are treatable. Bacterial STIs — chlamydia, gonorrhoea, and syphilis — are fully curable with antibiotics when diagnosed promptly. Viral STIs — HIV, herpes, HPV, and hepatitis B — cannot be cured but can be effectively managed. HIV is controlled with ART to the point of undetectability. Herpes is managed with antivirals that suppress outbreaks. HPV often clears naturally within 1–2 years in people with healthy immune systems. Genital warts can be treated and removed, though the underlying HPV virus may persist. The key message: all STIs are manageable with prompt diagnosis and treatment.
Yes. HIV is now a manageable chronic condition, not a death sentence. With antiretroviral therapy (ART), people with HIV can live long, healthy lives with a normal life expectancy. ART suppresses the virus to undetectable levels in the blood, meaning it cannot be transmitted sexually (Undetectable = Untransmittable, or U=U). Most people on modern ART take a single tablet daily and experience minimal side effects. HIV does not prevent you from having children, working, or having a fulfilling life. In the UK, HIV care is excellent and free on the NHS. The biggest barrier to good outcomes is late diagnosis — testing early is life-saving.
PEP (post-exposure prophylaxis) is a 28-day course of antiretroviral drugs that prevents HIV infection after a potential exposure. It must be started within 72 hours — the sooner the better. PEP is available from A&E departments, sexual health clinics, and some GUM clinics 24/7. It is free on the NHS for NHS patients. PEP is not a substitute for PrEP or condoms and should be used only in genuine emergencies (unprotected sex with a known HIV-positive person not on suppressive ART, condom failure, sexual assault, or needlestick). After completing PEP, an HIV test at 45 days and 3 months confirms whether infection was prevented.
Yes, but safely. With modern antiviral suppression, the risk of transmitting herpes to a partner is substantially reduced. Daily suppressive valaciclovir reduces transmission risk by approximately 50%, combined with condom use. Disclosing herpes to a new partner is an important conversation — most people with herpes have had it from a previous partner without knowing. Your sexual health clinician can help with disclosure conversations and partner testing. Most people with herpes continue to have satisfying, loving relationships. Herpes is extremely common — HSV-2 affects around 1 in 6 adults — and carries significant social stigma disproportionate to its medical impact.
Without treatment, chlamydia can persist silently for months or years, causing progressive damage to the reproductive tract. In women, untreated chlamydia causes pelvic inflammatory disease (PID) in 10–15% of cases, leading to tubal factor infertility, chronic pelvic pain, and ectopic pregnancy risk increased 6–10-fold. In men, chlamydia causes epididymo-orchitis, which can impair sperm production and quality. Reactive arthritis (formerly Reiter's syndrome) — involving joint inflammation, eye inflammation, and urethritis — is a rare but recognised complication. These complications are entirely preventable with prompt diagnosis and a simple 7-day course of doxycycline.
Gonorrhoea is increasingly difficult to treat due to rising antibiotic resistance. The current UK first-line treatment is a single intramuscular injection of ceftriaxone 1g. A test of cure is required 2 weeks later to confirm eradication. Azithromycin is no longer recommended routinely due to resistance. Multidrug-resistant gonorrhoea has been identified in multiple countries, including the UK. If you have been treated for gonorrhoea and symptoms persist, return to the clinic immediately — do not take additional antibiotics without guidance. Treatment of all recent sexual partners is essential to prevent reinfection.